DIABETES DRUGS LINKED TO
SERIOUS SIDE EFFECTS:
DIABETES DRUGS LINKED TO
SERIOUS SIDE EFFECTS:
• AMPUTATIONS
• KIDNEY FAILURE
• GANGRENE
• OTHER SERIOUS INJURIES
Have you or a loved one been diagnosed with Gangrene, Kidney Failure, or received an amputation after taking invokana®, farxiga®, jardinace®, or another SGLT2 inhibitor?
YOU MAY BE ENTITLED TO COMPENSATION
By clicking the "SUBMIT" button, I consent to receive recurring auto dialed and/or text messages from Shield Legal LP, and Tort Intake Professionals LLC or our partners in order to discuss my legal options and at the telephone number I provided. I also consent to the Shield Legal LP Privacy Policy and Terms of Use. I understand that I may receive a call even if my telephone number is listed on a Do Not Call list and that my consent is not a requirement of purchase. I understand that my telephone company may impose charges on me for these contacts and that I can revoke this consent at any time. For SMS campaigns: Text STOP to cancel and HELP for help. Msg & data rates may apply. Recurring msgs up to 27 msgs per month.
JOHNSON &
JOHNSON®
AGREES TO SETTLE A LARGE NUMBER OF INVOKANA® LAWSUITS
(OCTOBER 2016)
The Risks
Many of those who were prescribed Invokana® or other SGLT2 inhibitor for the treatment of their Type 2 diabetes have suffered severe adverse side effects as a result of taking the drug. Because Invokana® functions through the kidneys, patients who take the drug may experience significant dehydration, which can lead to dangerous consequences especially in those with diabetes.
This dehydration can compromise blood flow to the arms, legs, and feet. For many patients suffering from diabetes, limited blood flow could lead to amputations. In 2016, the FDA responded to these adverse effects by issuing a warning regarding the effects of the drug through research that was conducted.
FDA APPROVES INVOKANA® FOR TYPE 2 DIABETES TREATMENT –
MARCH 2013
FDA IS NOTIFIED OF 450 ADVERSE EVENTS LINKED TO INVOKANA® –
MAY 2015
WARNING ISSUED BY FDA TO THE PUBLIC REGARDING INVOKANA® –
AUGUST 2016
FDA ISSUES "BLACK BOX" WARNING FOR INVOKANA® –
MAY 2017
100% FREE CASE EVALUATION WITH EXPERIENCED & TRUSTED LAW FIRMS. SEE IF YOU QUALIFY TODAY!
Please seek the advice of a medical professional before making health care decisions. This advertisement is not associated with Invokana®, Farxiga®, Jardinace®, or Janssen Pharmaceuticals®, a registered trademark of Johnson & Johnson®, or any government agency.
ATTORNEY ADVERTISING. This Website is not intended to provide medical advice. Consult your doctor or physician before starting or stopping any medication.
Discontinuing a prescribed medication without your doctor’s advice can result in injury or death. Recoveries are not an indication of future results. Every case is evaluated on its own facts and circumstances. Valuation depends on facts, injuries, jurisdiction, venue, witnesses, parties, and testimony, among other factors. No representation is made that the quality of legal services to be performed is greater than the quality of legal services performed by other lawyers. Shield Legal does not itself provide legal services. Cases will be referred to third party attorneys and law firms. Do not rely on this advertisement in making any medical decision. Please call your physician before making any medical decision, including altering your use of any drug. Court costs and case expenses may be the responsibility of the client. Not available in all states. This advertisement is not intended as a testimonial, endorsement or dramatization, and does not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter, either express or implied. Anyone considering a lawyer should independently investigate the lawyers' credentials and ability, and not rely upon advertisements or self-proclaimed expertise.
Powered by
© 2019 Shield Legal LLC. All Rights Reserved.
